Jeremy Y C Teoh1, Samson Y S Chan1, Peter K F Chiu1, Darren M C Poon2, Ho-Yuen Cheung3, Simon S M Hou1, Chi-Fai Ng1. 1. Division of Urology, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, China. 2. Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, China. 3. Division of Urology, Department of Surgery, North District Hospital, Hong Kong, China.
Abstract
OBJECTIVE: To investigate the risk of acute myocardial infarction (AMI) after androgen-deprivation therapy (ADT) for prostate cancer in a Chinese population. PATIENTS AND METHODS: All Chinese patients with prostate cancer who were treated primarily with radical prostatectomy or radiotherapy, with or without further ADT at our hospital from the year 2000 to 2009 were retrospectively reviewed. We compared the risk of AMI in the patients who were given further ADT (ADT group) with those who were not given any ADT (non-ADT group). Potential risk factors of AMI including age, diabetes mellitus, hypertension, hyperlipidaemia, history of stroke, ischaemic heart disease, Eastern Cooperative Oncology Group Performance Status (ECOG PS) and duration of ADT were reviewed. The risk of AMI after ADT was first analysed using the Kaplan-Meier method, followed by Cox regression analyses including the potential risk factors mentioned. RESULTS: In all, 452 patients were included, with 200 patients in the non-ADT group and 252 patients in the ADT group. The mean (sd) age was 68.2 (5.9) years in the non-ADT group and 69.5 (6.5) years in the ADT group, and the difference was statistically significant (P = 0.031). There were no significant differences in their pre-existing medical conditions or ECOG PS. The ADT group was associated with an increased risk of AMI when compared with the non-ADT group (P = 0.004) upon Kaplan-Meier analysis. Upon multivariate Cox regression analysis, hyperlipidaemia, poor ECOG PS and the use of ADT were the only three significant factors that were associated with increased risk of developing new AMI. CONCLUSIONS: There was increased risk of AMI after ADT for prostate cancer in a Chinese population. Hyperlipidaemia and poor ECOG PS were also significant risk factors for developing AMI. The risk of AMI should be considered when deciding on ADT, especially in patients with history of hyperlipidaemia and relatively poor ECOG PS.
OBJECTIVE: To investigate the risk of acute myocardial infarction (AMI) after androgen-deprivation therapy (ADT) for prostate cancer in a Chinese population. PATIENTS AND METHODS: All Chinese patients with prostate cancer who were treated primarily with radical prostatectomy or radiotherapy, with or without further ADT at our hospital from the year 2000 to 2009 were retrospectively reviewed. We compared the risk of AMI in the patients who were given further ADT (ADT group) with those who were not given any ADT (non-ADT group). Potential risk factors of AMI including age, diabetes mellitus, hypertension, hyperlipidaemia, history of stroke, ischaemic heart disease, Eastern Cooperative Oncology Group Performance Status (ECOG PS) and duration of ADT were reviewed. The risk of AMI after ADT was first analysed using the Kaplan-Meier method, followed by Cox regression analyses including the potential risk factors mentioned. RESULTS: In all, 452 patients were included, with 200 patients in the non-ADT group and 252 patients in the ADT group. The mean (sd) age was 68.2 (5.9) years in the non-ADT group and 69.5 (6.5) years in the ADT group, and the difference was statistically significant (P = 0.031). There were no significant differences in their pre-existing medical conditions or ECOG PS. The ADT group was associated with an increased risk of AMI when compared with the non-ADT group (P = 0.004) upon Kaplan-Meier analysis. Upon multivariate Cox regression analysis, hyperlipidaemia, poor ECOG PS and the use of ADT were the only three significant factors that were associated with increased risk of developing new AMI. CONCLUSIONS: There was increased risk of AMI after ADT for prostate cancer in a Chinese population. Hyperlipidaemia and poor ECOG PS were also significant risk factors for developing AMI. The risk of AMI should be considered when deciding on ADT, especially in patients with history of hyperlipidaemia and relatively poor ECOG PS.
Authors: Thiago Gagliano-Jucá; Karol M Pencina; Tomas Ganz; Thomas G Travison; Philip W Kantoff; Paul L Nguyen; Mary-Ellen Taplin; Adam S Kibel; Zhuoying Li; Grace Huang; Robert R Edwards; Elizabeta Nemeth; Shehzad Basaria Journal: Am J Physiol Endocrinol Metab Date: 2018-10-16 Impact factor: 4.310
Authors: Chris Wong; Peggy Chu; Jeremy Teoh; Peter Chiu; C H Yee; Lysander Chau; Marco Chan; Helen Wan; Steven Leung; C F Ng Journal: Int Urol Nephrol Date: 2022-02-25 Impact factor: 2.370
Authors: Joseph K M Li; Lynn L Wang; Christine Y P Wong; Peter K F Chiu; Jeremy Y C Teoh; Hilda S W Kwok; Steven C H Leung; Sunny H Wong; Stephen K W Tsui; Chi-Fai Ng Journal: Prostate Cancer Prostatic Dis Date: 2021-04-13 Impact factor: 5.455
Authors: Myungsun Shim; Woo Jin Bang; Cheol Young Oh; Yong Seong Lee; Seong Soo Jeon; Hanjong Ahn; Young-Su Ju; Jin Seon Cho Journal: PLoS One Date: 2020-12-30 Impact factor: 3.240
Authors: Hsin-Le Lin; Chia-Yi Lee; Jing-Yang Huang; Po-Chen Tseng; Shun-Fa Yang Journal: Int J Environ Res Public Health Date: 2022-02-17 Impact factor: 3.390
Authors: Youquan Li; Whee Sze Ong; Ma Than Than Shwe; Nelson Ling Fung Yit; Sheriff Zhan Hong Quek; Eric Pei Ping Pang; Wen Shen Looi; Wen Long Nei; Michael Lian Chek Wang; Melvin Lee Kiang Chua; Terence Wee Kiat Tan; Eu Tiong Chua; Choon Ta Ng; Jeffrey Kit Loong Tuan Journal: Cardiooncology Date: 2022-03-14
Authors: Chi-Fai Ng; Peter K F Chiu; Chi-Hang Yee; Becky S Y Lau; Steven C H Leung; Jeremy Y C Teoh Journal: Sci Rep Date: 2020-10-22 Impact factor: 4.379